Gene expression property of high-density three-dimensional tissue of HepG2 cells formed in radial-flow bioreactor.
In our previous study, we examined three-dimensional culture using 5-ml radial-flow bioreactor (RFB) and showed that genes encoding cell cycle related proteins were suppressed in a stable phase. In this study, we analyzed the gene expression profiles of RFB-cultivated HepG2 cells and found that vascular endothelial growth factor (VEGF) production was strongly induced in the stable phase compared with the growth phase or static two-dimensional culture. When human umbilical vein endothelial cells (HUVECs) were grown under the conditioned medium of the stable phase, it was found that the formation of new blood vessels was induced in the angiogenesis model. DNA microarray analysis showed that the expression levels of both genes related to cell cycle arrest and which are known as tumor markers have increased in the stable phase. This result suggests that HepG2 cells in the stable phase maintain an active tumor phenotype. In addition, the expression of genes induced in the hypoxic condition was also induced in the stable phase. When the culture was carried out under a higher dissolved oxygen (DO) concentration, VEGF production did not decrease significantly and the new blood-vessel-forming ability of the conditioned medium was not suppressed. This suggests that the induction of VEGF production in a stable phase is not affected by DO during the tested level. These results suggest that the RFB cell culture system may be used to assess tumor progression mechanism under three-dimensional condition in vitro.
Hongo
Tomokatsu
T
ABLE Corporation, 4-15 Higashigoken-cho, Shinjyuku-ku, Tokyo 162-0813, Japan.
Kajikawa
Mariko
M
Ishida
Seiichi
S
Ozawa
Shogo
S
Ohno
Yasuo
Y
Sawada
Jun-ichi
J
Ishikawa
Yoichi
Y
Honda
Hiroyuki
H
D014408:Biomarkers, Tumor; D019149:Bioreactors; D049109:Cell Proliferation; D002478:Cells, Cultured; D017077:Culture Media, Conditioned / Q000378:metabolism; D042783:Endothelial Cells / Q000166:cytology; D015870:Gene Expression; D005786:Gene Expression Regulation; D006801:Humans; D000860:Hypoxia; D009389:Neovascularization, Pathologic; D020411:Oligonucleotide Array Sequence Analysis; D010100:Oxygen / Q000737:chemistry; D014471:Umbilical Veins / Q000166:cytology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D014408:Biomarkers, Tumor; D017077:Culture Media, Conditioned; D042461:Vascular Endothelial Growth Factor A; D010100:Oxygen